Can We Reverse Age-Related Vision Loss?
A new experimental drug from longevity biotech company Life Biosciences is pushing the boundaries of what modern medicine thinks is possible. The therapy, called ER-100, is now in early human clinical trials and it carries a bold promise: the potential to reverse age-related vision loss.
It sounds like science fiction. But behind the headlines is a serious attempt to address one of the most difficult problems in medicine: repairing the aging nervous system.
What makes ER-100 so intriguing is its underlying philosophy: instead of simply protecting remaining vision, it aims to rejuvenate damaged cells.
The drug is part of a growing field of research focused on cellular rejuvenation, sometimes referred to as partial cellular reprogramming. The idea is to help aging or dysfunctional cells regain more youthful behavior and function, without fully replacing them.
In theory, this could mean improving the health of optic nerve cells, enhancing their energy production, and restoring communication pathways that degrade with age or injury.
Rather than treating symptoms, the goal is to address one of the root contributors, cellular aging itself.
I’ll just keep not wearing my glasses until they figure that out!
Lana Backman
